Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic Leukemia

  • STATUS
    Recruiting
  • days left to enroll
    88
  • participants needed
    60
  • sponsor
    Ain Shams University
Updated on 24 September 2021

Summary

Assessment of of the biological effects of curcumin on microbiota in children with acute lymphoblastic leukemia

Description

Assessment of the safety of curcumin, which is the most active constituent of the ground rhizome of the Curcuma longa plant, in children with acute lymphoblastic leukemia patients (ALL) in maintenance phase of chemotherapy through the assessment of the any reported adverse event (AE). And assessment of the curcumin effect on health by eliminating intestinal microflora dysbiosis

Details
Condition Lymphocytic Leukemia, Acute, childhood ALL
Treatment Standard of Care, Curcumin
Clinical Study IdentifierNCT05045443
SponsorAin Shams University
Last Modified on24 September 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Children aged from 1 year to 18 years Children with proven ALL diagnosed by
bone marrow aspirate and immunephenotyping Patients in the maintenance phase
week1

Exclusion Criteria

Children with other maliganacies, Current use (past use of these medications
is not an exclusion) of medications or over-the-counter treatments including
to sulfasalazine, warfarin, clopidogrel, aspirin, antacids, botanical
treatments (ginger, feverfew, yellow clover, Salix species, Populus species
Betula species, and Gaultheria species), essential fatty acids (flax oil and
fish oil)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note